Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Growth 2026-2032
The global Prostate-Specific Membrane Antigen(PSMA) Inhibitor market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Prostate-Specific Membrane Antigen(PSMA) Inhibitors are a class of drugs that target specific antigens on the surface of prostate cancer cells. These inhibitors block the growth and spread of tumor cells by binding to PSMA and are often used in targeted therapy and imaging studies.
United States market for Prostate-Specific Membrane Antigen(PSMA) Inhibitor is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Prostate-Specific Membrane Antigen(PSMA) Inhibitor is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Prostate-Specific Membrane Antigen(PSMA) Inhibitor is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Prostate-Specific Membrane Antigen(PSMA) Inhibitor players cover TargetMol, Merck KGaA, DC Chemicals, Biorbyt, MedChemExpress, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Prostate-Specific Membrane Antigen(PSMA) Inhibitor Industry Forecast” looks at past sales and reviews total world Prostate-Specific Membrane Antigen(PSMA) Inhibitor sales in 2025, providing a comprehensive analysis by region and market sector of projected Prostate-Specific Membrane Antigen(PSMA) Inhibitor sales for 2026 through 2032. With Prostate-Specific Membrane Antigen(PSMA) Inhibitor sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prostate-Specific Membrane Antigen(PSMA) Inhibitor industry.
This Insight Report provides a comprehensive analysis of the global Prostate-Specific Membrane Antigen(PSMA) Inhibitor landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Prostate-Specific Membrane Antigen(PSMA) Inhibitor portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Prostate-Specific Membrane Antigen(PSMA) Inhibitor market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prostate-Specific Membrane Antigen(PSMA) Inhibitor and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prostate-Specific Membrane Antigen(PSMA) Inhibitor.
This report presents a comprehensive overview, market shares, and growth opportunities of Prostate-Specific Membrane Antigen(PSMA) Inhibitor market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Prostate-Specific Membrane Antigen(PSMA) Inhibitors are a class of drugs that target specific antigens on the surface of prostate cancer cells. These inhibitors block the growth and spread of tumor cells by binding to PSMA and are often used in targeted therapy and imaging studies.
United States market for Prostate-Specific Membrane Antigen(PSMA) Inhibitor is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Prostate-Specific Membrane Antigen(PSMA) Inhibitor is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Prostate-Specific Membrane Antigen(PSMA) Inhibitor is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Prostate-Specific Membrane Antigen(PSMA) Inhibitor players cover TargetMol, Merck KGaA, DC Chemicals, Biorbyt, MedChemExpress, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Prostate-Specific Membrane Antigen(PSMA) Inhibitor Industry Forecast” looks at past sales and reviews total world Prostate-Specific Membrane Antigen(PSMA) Inhibitor sales in 2025, providing a comprehensive analysis by region and market sector of projected Prostate-Specific Membrane Antigen(PSMA) Inhibitor sales for 2026 through 2032. With Prostate-Specific Membrane Antigen(PSMA) Inhibitor sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prostate-Specific Membrane Antigen(PSMA) Inhibitor industry.
This Insight Report provides a comprehensive analysis of the global Prostate-Specific Membrane Antigen(PSMA) Inhibitor landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Prostate-Specific Membrane Antigen(PSMA) Inhibitor portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Prostate-Specific Membrane Antigen(PSMA) Inhibitor market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prostate-Specific Membrane Antigen(PSMA) Inhibitor and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prostate-Specific Membrane Antigen(PSMA) Inhibitor.
This report presents a comprehensive overview, market shares, and growth opportunities of Prostate-Specific Membrane Antigen(PSMA) Inhibitor market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Small Molecule Inhibitors
- Peptide Inhibitors
- Other
- Scientific Research
- Pharmaceuticals
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- TargetMol
- Merck KGaA
- DC Chemicals
- Biorbyt
- MedChemExpress
- QYAOBIO
- ACROBiosystems Group
- Shanghai Apeptide Co
- Xi'an Ruixi Biotechnology Co., Ltd.
- SNDPHARM TSCHNOLOFY
- Hangzhou MolCore BioPharmatech
- What is the 10-year outlook for the global Prostate-Specific Membrane Antigen(PSMA) Inhibitor market?
- What factors are driving Prostate-Specific Membrane Antigen(PSMA) Inhibitor market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Prostate-Specific Membrane Antigen(PSMA) Inhibitor market opportunities vary by end market size?
- How does Prostate-Specific Membrane Antigen(PSMA) Inhibitor break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Prostate-Specific Membrane Antigen(PSMA) Inhibitor by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Prostate-Specific Membrane Antigen(PSMA) Inhibitor by Country/Region, 2021, 2025 & 2032
2.2 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Segment by Type
2.2.1 Small Molecule Inhibitors
2.2.2 Peptide Inhibitors
2.2.3 Other
2.2.4 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Type
2.2.4.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Type (2021-2026)
2.2.4.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sale Price by Type (2021-2026)
2.3 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Segment by Application
2.3.1 Scientific Research
2.3.2 Pharmaceuticals
2.3.3 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Application
2.3.3.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sale Market Share by Application (2021-2026)
2.3.3.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Breakdown Data by Company
3.1.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Annual Sales by Company (2021-2026)
3.1.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Company (2021-2026)
3.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Annual Revenue by Company (2021-2026)
3.2.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Company (2021-2026)
3.2.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Company (2021-2026)
3.3 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sale Price by Company
3.4 Key Manufacturers Prostate-Specific Membrane Antigen(PSMA) Inhibitor Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Location Distribution
3.4.2 Players Prostate-Specific Membrane Antigen(PSMA) Inhibitor Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PROSTATE-SPECIFIC MEMBRANE ANTIGEN(PSMA) INHIBITOR BY GEOGRAPHIC REGION
4.1 World Historic Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Size by Geographic Region (2021-2026)
4.1.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Size by Country/Region (2021-2026)
4.2.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Annual Sales by Country/Region (2021-2026)
4.2.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Annual Revenue by Country/Region (2021-2026)
4.3 Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Growth
4.4 APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Growth
4.5 Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Growth
4.6 Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Growth
5 AMERICAS
5.1 Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Country
5.1.1 Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Country (2021-2026)
5.1.2 Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Country (2021-2026)
5.2 Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Type (2021-2026)
5.3 Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Region
6.1.1 APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Region (2021-2026)
6.1.2 APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Region (2021-2026)
6.2 APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Type (2021-2026)
6.3 APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor by Country
7.1.1 Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Country (2021-2026)
7.1.2 Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Country (2021-2026)
7.2 Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Type (2021-2026)
7.3 Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor by Country
8.1.1 Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Country (2021-2026)
8.1.2 Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Country (2021-2026)
8.2 Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Type (2021-2026)
8.3 Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Prostate-Specific Membrane Antigen(PSMA) Inhibitor
10.3 Manufacturing Process Analysis of Prostate-Specific Membrane Antigen(PSMA) Inhibitor
10.4 Industry Chain Structure of Prostate-Specific Membrane Antigen(PSMA) Inhibitor
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Distributors
11.3 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Customer
12 WORLD FORECAST REVIEW FOR PROSTATE-SPECIFIC MEMBRANE ANTIGEN(PSMA) INHIBITOR BY GEOGRAPHIC REGION
12.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Size Forecast by Region
12.1.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Forecast by Region (2027-2032)
12.1.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Forecast by Type (2027-2032)
12.7 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 TargetMol
13.1.1 TargetMol Company Information
13.1.2 TargetMol Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
13.1.3 TargetMol Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 TargetMol Main Business Overview
13.1.5 TargetMol Latest Developments
13.2 Merck KGaA
13.2.1 Merck KGaA Company Information
13.2.2 Merck KGaA Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
13.2.3 Merck KGaA Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Merck KGaA Main Business Overview
13.2.5 Merck KGaA Latest Developments
13.3 DC Chemicals
13.3.1 DC Chemicals Company Information
13.3.2 DC Chemicals Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
13.3.3 DC Chemicals Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 DC Chemicals Main Business Overview
13.3.5 DC Chemicals Latest Developments
13.4 Biorbyt
13.4.1 Biorbyt Company Information
13.4.2 Biorbyt Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
13.4.3 Biorbyt Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Biorbyt Main Business Overview
13.4.5 Biorbyt Latest Developments
13.5 MedChemExpress
13.5.1 MedChemExpress Company Information
13.5.2 MedChemExpress Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
13.5.3 MedChemExpress Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 MedChemExpress Main Business Overview
13.5.5 MedChemExpress Latest Developments
13.6 QYAOBIO
13.6.1 QYAOBIO Company Information
13.6.2 QYAOBIO Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
13.6.3 QYAOBIO Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 QYAOBIO Main Business Overview
13.6.5 QYAOBIO Latest Developments
13.7 ACROBiosystems Group
13.7.1 ACROBiosystems Group Company Information
13.7.2 ACROBiosystems Group Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
13.7.3 ACROBiosystems Group Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 ACROBiosystems Group Main Business Overview
13.7.5 ACROBiosystems Group Latest Developments
13.8 Shanghai Apeptide Co
13.8.1 Shanghai Apeptide Co Company Information
13.8.2 Shanghai Apeptide Co Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
13.8.3 Shanghai Apeptide Co Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Shanghai Apeptide Co Main Business Overview
13.8.5 Shanghai Apeptide Co Latest Developments
13.9 Xi'an Ruixi Biotechnology Co., Ltd.
13.9.1 Xi'an Ruixi Biotechnology Co., Ltd. Company Information
13.9.2 Xi'an Ruixi Biotechnology Co., Ltd. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
13.9.3 Xi'an Ruixi Biotechnology Co., Ltd. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Xi'an Ruixi Biotechnology Co., Ltd. Main Business Overview
13.9.5 Xi'an Ruixi Biotechnology Co., Ltd. Latest Developments
13.10 SNDPHARM TSCHNOLOFY
13.10.1 SNDPHARM TSCHNOLOFY Company Information
13.10.2 SNDPHARM TSCHNOLOFY Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
13.10.3 SNDPHARM TSCHNOLOFY Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 SNDPHARM TSCHNOLOFY Main Business Overview
13.10.5 SNDPHARM TSCHNOLOFY Latest Developments
13.11 Hangzhou MolCore BioPharmatech
13.11.1 Hangzhou MolCore BioPharmatech Company Information
13.11.2 Hangzhou MolCore BioPharmatech Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
13.11.3 Hangzhou MolCore BioPharmatech Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Hangzhou MolCore BioPharmatech Main Business Overview
13.11.5 Hangzhou MolCore BioPharmatech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Prostate-Specific Membrane Antigen(PSMA) Inhibitor by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Prostate-Specific Membrane Antigen(PSMA) Inhibitor by Country/Region, 2021, 2025 & 2032
2.2 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Segment by Type
2.2.1 Small Molecule Inhibitors
2.2.2 Peptide Inhibitors
2.2.3 Other
2.2.4 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Type
2.2.4.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Type (2021-2026)
2.2.4.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sale Price by Type (2021-2026)
2.3 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Segment by Application
2.3.1 Scientific Research
2.3.2 Pharmaceuticals
2.3.3 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Application
2.3.3.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sale Market Share by Application (2021-2026)
2.3.3.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Breakdown Data by Company
3.1.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Annual Sales by Company (2021-2026)
3.1.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Company (2021-2026)
3.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Annual Revenue by Company (2021-2026)
3.2.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Company (2021-2026)
3.2.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Company (2021-2026)
3.3 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sale Price by Company
3.4 Key Manufacturers Prostate-Specific Membrane Antigen(PSMA) Inhibitor Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Location Distribution
3.4.2 Players Prostate-Specific Membrane Antigen(PSMA) Inhibitor Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PROSTATE-SPECIFIC MEMBRANE ANTIGEN(PSMA) INHIBITOR BY GEOGRAPHIC REGION
4.1 World Historic Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Size by Geographic Region (2021-2026)
4.1.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Size by Country/Region (2021-2026)
4.2.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Annual Sales by Country/Region (2021-2026)
4.2.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Annual Revenue by Country/Region (2021-2026)
4.3 Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Growth
4.4 APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Growth
4.5 Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Growth
4.6 Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Growth
5 AMERICAS
5.1 Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Country
5.1.1 Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Country (2021-2026)
5.1.2 Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Country (2021-2026)
5.2 Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Type (2021-2026)
5.3 Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Region
6.1.1 APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Region (2021-2026)
6.1.2 APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Region (2021-2026)
6.2 APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Type (2021-2026)
6.3 APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor by Country
7.1.1 Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Country (2021-2026)
7.1.2 Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Country (2021-2026)
7.2 Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Type (2021-2026)
7.3 Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor by Country
8.1.1 Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Country (2021-2026)
8.1.2 Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Country (2021-2026)
8.2 Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Type (2021-2026)
8.3 Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Prostate-Specific Membrane Antigen(PSMA) Inhibitor
10.3 Manufacturing Process Analysis of Prostate-Specific Membrane Antigen(PSMA) Inhibitor
10.4 Industry Chain Structure of Prostate-Specific Membrane Antigen(PSMA) Inhibitor
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Distributors
11.3 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Customer
12 WORLD FORECAST REVIEW FOR PROSTATE-SPECIFIC MEMBRANE ANTIGEN(PSMA) INHIBITOR BY GEOGRAPHIC REGION
12.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Size Forecast by Region
12.1.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Forecast by Region (2027-2032)
12.1.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Forecast by Type (2027-2032)
12.7 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 TargetMol
13.1.1 TargetMol Company Information
13.1.2 TargetMol Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
13.1.3 TargetMol Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 TargetMol Main Business Overview
13.1.5 TargetMol Latest Developments
13.2 Merck KGaA
13.2.1 Merck KGaA Company Information
13.2.2 Merck KGaA Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
13.2.3 Merck KGaA Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Merck KGaA Main Business Overview
13.2.5 Merck KGaA Latest Developments
13.3 DC Chemicals
13.3.1 DC Chemicals Company Information
13.3.2 DC Chemicals Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
13.3.3 DC Chemicals Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 DC Chemicals Main Business Overview
13.3.5 DC Chemicals Latest Developments
13.4 Biorbyt
13.4.1 Biorbyt Company Information
13.4.2 Biorbyt Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
13.4.3 Biorbyt Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Biorbyt Main Business Overview
13.4.5 Biorbyt Latest Developments
13.5 MedChemExpress
13.5.1 MedChemExpress Company Information
13.5.2 MedChemExpress Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
13.5.3 MedChemExpress Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 MedChemExpress Main Business Overview
13.5.5 MedChemExpress Latest Developments
13.6 QYAOBIO
13.6.1 QYAOBIO Company Information
13.6.2 QYAOBIO Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
13.6.3 QYAOBIO Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 QYAOBIO Main Business Overview
13.6.5 QYAOBIO Latest Developments
13.7 ACROBiosystems Group
13.7.1 ACROBiosystems Group Company Information
13.7.2 ACROBiosystems Group Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
13.7.3 ACROBiosystems Group Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 ACROBiosystems Group Main Business Overview
13.7.5 ACROBiosystems Group Latest Developments
13.8 Shanghai Apeptide Co
13.8.1 Shanghai Apeptide Co Company Information
13.8.2 Shanghai Apeptide Co Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
13.8.3 Shanghai Apeptide Co Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Shanghai Apeptide Co Main Business Overview
13.8.5 Shanghai Apeptide Co Latest Developments
13.9 Xi'an Ruixi Biotechnology Co., Ltd.
13.9.1 Xi'an Ruixi Biotechnology Co., Ltd. Company Information
13.9.2 Xi'an Ruixi Biotechnology Co., Ltd. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
13.9.3 Xi'an Ruixi Biotechnology Co., Ltd. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Xi'an Ruixi Biotechnology Co., Ltd. Main Business Overview
13.9.5 Xi'an Ruixi Biotechnology Co., Ltd. Latest Developments
13.10 SNDPHARM TSCHNOLOFY
13.10.1 SNDPHARM TSCHNOLOFY Company Information
13.10.2 SNDPHARM TSCHNOLOFY Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
13.10.3 SNDPHARM TSCHNOLOFY Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 SNDPHARM TSCHNOLOFY Main Business Overview
13.10.5 SNDPHARM TSCHNOLOFY Latest Developments
13.11 Hangzhou MolCore BioPharmatech
13.11.1 Hangzhou MolCore BioPharmatech Company Information
13.11.2 Hangzhou MolCore BioPharmatech Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
13.11.3 Hangzhou MolCore BioPharmatech Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Hangzhou MolCore BioPharmatech Main Business Overview
13.11.5 Hangzhou MolCore BioPharmatech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Small Molecule Inhibitors
Table 4. Major Players of Peptide Inhibitors
Table 5. Major Players of Other
Table 6. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Type (2021-2026) & (kg)
Table 7. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Type (2021-2026)
Table 8. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Type (2021-2026) & ($ million)
Table 9. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Type (2021-2026)
Table 10. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sale Price by Type (2021-2026) & (US$/g)
Table 11. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sale by Application (2021-2026) & (kg)
Table 12. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sale Market Share by Application (2021-2026)
Table 13. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Application (2021-2026) & ($ million)
Table 14. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Application (2021-2026)
Table 15. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sale Price by Application (2021-2026) & (US$/g)
Table 16. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Company (2021-2026) & (kg)
Table 17. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Company (2021-2026)
Table 18. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Company (2021-2026)
Table 20. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sale Price by Company (2021-2026) & (US$/g)
Table 21. Key Manufacturers Prostate-Specific Membrane Antigen(PSMA) Inhibitor Producing Area Distribution and Sales Area
Table 22. Players Prostate-Specific Membrane Antigen(PSMA) Inhibitor Products Offered
Table 23. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Geographic Region (2021-2026) & (kg)
Table 27. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share Geographic Region (2021-2026)
Table 28. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Country/Region (2021-2026) & (kg)
Table 31. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Country/Region (2021-2026)
Table 32. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Country (2021-2026) & (kg)
Table 35. Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Country (2021-2026)
Table 36. Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Type (2021-2026) & (kg)
Table 38. Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Application (2021-2026) & (kg)
Table 39. APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Region (2021-2026) & (kg)
Table 40. APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Region (2021-2026)
Table 41. APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Type (2021-2026) & (kg)
Table 43. APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Application (2021-2026) & (kg)
Table 44. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Country (2021-2026) & (kg)
Table 45. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Type (2021-2026) & (kg)
Table 47. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Application (2021-2026) & (kg)
Table 48. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Country (2021-2026) & (kg)
Table 49. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Type (2021-2026) & (kg)
Table 51. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Application (2021-2026) & (kg)
Table 52. Key Market Drivers & Growth Opportunities of Prostate-Specific Membrane Antigen(PSMA) Inhibitor
Table 53. Key Market Challenges & Risks of Prostate-Specific Membrane Antigen(PSMA) Inhibitor
Table 54. Key Industry Trends of Prostate-Specific Membrane Antigen(PSMA) Inhibitor
Table 55. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Distributors List
Table 58. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Customer List
Table 59. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Forecast by Region (2027-2032) & (kg)
Table 60. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Forecast by Country (2027-2032) & (kg)
Table 62. Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Forecast by Region (2027-2032) & (kg)
Table 64. APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Forecast by Country (2027-2032) & (kg)
Table 66. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Forecast by Country (2027-2032) & (kg)
Table 68. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Forecast by Type (2027-2032) & (kg)
Table 70. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Forecast by Application (2027-2032) & (kg)
Table 72. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. TargetMol Basic Information, Prostate-Specific Membrane Antigen(PSMA) Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 74. TargetMol Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
Table 75. TargetMol Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 76. TargetMol Main Business
Table 77. TargetMol Latest Developments
Table 78. Merck KGaA Basic Information, Prostate-Specific Membrane Antigen(PSMA) Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck KGaA Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
Table 80. Merck KGaA Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 81. Merck KGaA Main Business
Table 82. Merck KGaA Latest Developments
Table 83. DC Chemicals Basic Information, Prostate-Specific Membrane Antigen(PSMA) Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 84. DC Chemicals Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
Table 85. DC Chemicals Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 86. DC Chemicals Main Business
Table 87. DC Chemicals Latest Developments
Table 88. Biorbyt Basic Information, Prostate-Specific Membrane Antigen(PSMA) Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 89. Biorbyt Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
Table 90. Biorbyt Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 91. Biorbyt Main Business
Table 92. Biorbyt Latest Developments
Table 93. MedChemExpress Basic Information, Prostate-Specific Membrane Antigen(PSMA) Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 94. MedChemExpress Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
Table 95. MedChemExpress Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 96. MedChemExpress Main Business
Table 97. MedChemExpress Latest Developments
Table 98. QYAOBIO Basic Information, Prostate-Specific Membrane Antigen(PSMA) Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 99. QYAOBIO Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
Table 100. QYAOBIO Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 101. QYAOBIO Main Business
Table 102. QYAOBIO Latest Developments
Table 103. ACROBiosystems Group Basic Information, Prostate-Specific Membrane Antigen(PSMA) Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 104. ACROBiosystems Group Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
Table 105. ACROBiosystems Group Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 106. ACROBiosystems Group Main Business
Table 107. ACROBiosystems Group Latest Developments
Table 108. Shanghai Apeptide Co Basic Information, Prostate-Specific Membrane Antigen(PSMA) Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 109. Shanghai Apeptide Co Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
Table 110. Shanghai Apeptide Co Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 111. Shanghai Apeptide Co Main Business
Table 112. Shanghai Apeptide Co Latest Developments
Table 113. Xi'an Ruixi Biotechnology Co., Ltd. Basic Information, Prostate-Specific Membrane Antigen(PSMA) Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 114. Xi'an Ruixi Biotechnology Co., Ltd. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
Table 115. Xi'an Ruixi Biotechnology Co., Ltd. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 116. Xi'an Ruixi Biotechnology Co., Ltd. Main Business
Table 117. Xi'an Ruixi Biotechnology Co., Ltd. Latest Developments
Table 118. SNDPHARM TSCHNOLOFY Basic Information, Prostate-Specific Membrane Antigen(PSMA) Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 119. SNDPHARM TSCHNOLOFY Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
Table 120. SNDPHARM TSCHNOLOFY Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 121. SNDPHARM TSCHNOLOFY Main Business
Table 122. SNDPHARM TSCHNOLOFY Latest Developments
Table 123. Hangzhou MolCore BioPharmatech Basic Information, Prostate-Specific Membrane Antigen(PSMA) Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 124. Hangzhou MolCore BioPharmatech Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
Table 125. Hangzhou MolCore BioPharmatech Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 126. Hangzhou MolCore BioPharmatech Main Business
Table 127. Hangzhou MolCore BioPharmatech Latest Developments
Table 1. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Small Molecule Inhibitors
Table 4. Major Players of Peptide Inhibitors
Table 5. Major Players of Other
Table 6. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Type (2021-2026) & (kg)
Table 7. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Type (2021-2026)
Table 8. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Type (2021-2026) & ($ million)
Table 9. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Type (2021-2026)
Table 10. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sale Price by Type (2021-2026) & (US$/g)
Table 11. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sale by Application (2021-2026) & (kg)
Table 12. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sale Market Share by Application (2021-2026)
Table 13. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Application (2021-2026) & ($ million)
Table 14. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Application (2021-2026)
Table 15. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sale Price by Application (2021-2026) & (US$/g)
Table 16. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Company (2021-2026) & (kg)
Table 17. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Company (2021-2026)
Table 18. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Company (2021-2026)
Table 20. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sale Price by Company (2021-2026) & (US$/g)
Table 21. Key Manufacturers Prostate-Specific Membrane Antigen(PSMA) Inhibitor Producing Area Distribution and Sales Area
Table 22. Players Prostate-Specific Membrane Antigen(PSMA) Inhibitor Products Offered
Table 23. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Geographic Region (2021-2026) & (kg)
Table 27. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share Geographic Region (2021-2026)
Table 28. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Country/Region (2021-2026) & (kg)
Table 31. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Country/Region (2021-2026)
Table 32. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Country (2021-2026) & (kg)
Table 35. Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Country (2021-2026)
Table 36. Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Type (2021-2026) & (kg)
Table 38. Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Application (2021-2026) & (kg)
Table 39. APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Region (2021-2026) & (kg)
Table 40. APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Region (2021-2026)
Table 41. APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Type (2021-2026) & (kg)
Table 43. APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Application (2021-2026) & (kg)
Table 44. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Country (2021-2026) & (kg)
Table 45. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Type (2021-2026) & (kg)
Table 47. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Application (2021-2026) & (kg)
Table 48. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Country (2021-2026) & (kg)
Table 49. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Type (2021-2026) & (kg)
Table 51. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Application (2021-2026) & (kg)
Table 52. Key Market Drivers & Growth Opportunities of Prostate-Specific Membrane Antigen(PSMA) Inhibitor
Table 53. Key Market Challenges & Risks of Prostate-Specific Membrane Antigen(PSMA) Inhibitor
Table 54. Key Industry Trends of Prostate-Specific Membrane Antigen(PSMA) Inhibitor
Table 55. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Distributors List
Table 58. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Customer List
Table 59. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Forecast by Region (2027-2032) & (kg)
Table 60. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Forecast by Country (2027-2032) & (kg)
Table 62. Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Forecast by Region (2027-2032) & (kg)
Table 64. APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Forecast by Country (2027-2032) & (kg)
Table 66. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Forecast by Country (2027-2032) & (kg)
Table 68. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Forecast by Type (2027-2032) & (kg)
Table 70. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Forecast by Application (2027-2032) & (kg)
Table 72. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. TargetMol Basic Information, Prostate-Specific Membrane Antigen(PSMA) Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 74. TargetMol Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
Table 75. TargetMol Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 76. TargetMol Main Business
Table 77. TargetMol Latest Developments
Table 78. Merck KGaA Basic Information, Prostate-Specific Membrane Antigen(PSMA) Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck KGaA Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
Table 80. Merck KGaA Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 81. Merck KGaA Main Business
Table 82. Merck KGaA Latest Developments
Table 83. DC Chemicals Basic Information, Prostate-Specific Membrane Antigen(PSMA) Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 84. DC Chemicals Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
Table 85. DC Chemicals Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 86. DC Chemicals Main Business
Table 87. DC Chemicals Latest Developments
Table 88. Biorbyt Basic Information, Prostate-Specific Membrane Antigen(PSMA) Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 89. Biorbyt Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
Table 90. Biorbyt Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 91. Biorbyt Main Business
Table 92. Biorbyt Latest Developments
Table 93. MedChemExpress Basic Information, Prostate-Specific Membrane Antigen(PSMA) Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 94. MedChemExpress Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
Table 95. MedChemExpress Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 96. MedChemExpress Main Business
Table 97. MedChemExpress Latest Developments
Table 98. QYAOBIO Basic Information, Prostate-Specific Membrane Antigen(PSMA) Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 99. QYAOBIO Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
Table 100. QYAOBIO Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 101. QYAOBIO Main Business
Table 102. QYAOBIO Latest Developments
Table 103. ACROBiosystems Group Basic Information, Prostate-Specific Membrane Antigen(PSMA) Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 104. ACROBiosystems Group Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
Table 105. ACROBiosystems Group Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 106. ACROBiosystems Group Main Business
Table 107. ACROBiosystems Group Latest Developments
Table 108. Shanghai Apeptide Co Basic Information, Prostate-Specific Membrane Antigen(PSMA) Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 109. Shanghai Apeptide Co Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
Table 110. Shanghai Apeptide Co Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 111. Shanghai Apeptide Co Main Business
Table 112. Shanghai Apeptide Co Latest Developments
Table 113. Xi'an Ruixi Biotechnology Co., Ltd. Basic Information, Prostate-Specific Membrane Antigen(PSMA) Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 114. Xi'an Ruixi Biotechnology Co., Ltd. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
Table 115. Xi'an Ruixi Biotechnology Co., Ltd. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 116. Xi'an Ruixi Biotechnology Co., Ltd. Main Business
Table 117. Xi'an Ruixi Biotechnology Co., Ltd. Latest Developments
Table 118. SNDPHARM TSCHNOLOFY Basic Information, Prostate-Specific Membrane Antigen(PSMA) Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 119. SNDPHARM TSCHNOLOFY Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
Table 120. SNDPHARM TSCHNOLOFY Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 121. SNDPHARM TSCHNOLOFY Main Business
Table 122. SNDPHARM TSCHNOLOFY Latest Developments
Table 123. Hangzhou MolCore BioPharmatech Basic Information, Prostate-Specific Membrane Antigen(PSMA) Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 124. Hangzhou MolCore BioPharmatech Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product Portfolios and Specifications
Table 125. Hangzhou MolCore BioPharmatech Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 126. Hangzhou MolCore BioPharmatech Main Business
Table 127. Hangzhou MolCore BioPharmatech Latest Developments
LIST OF FIGURES
Figure 1. Picture of Prostate-Specific Membrane Antigen(PSMA) Inhibitor
Figure 2. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Growth Rate 2021-2032 (kg)
Figure 7. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Country/Region (2025)
Figure 10. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Small Molecule Inhibitors
Figure 12. Product Picture of Peptide Inhibitors
Figure 13. Product Picture of Other
Figure 14. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Type in 2026
Figure 15. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Type (2021-2026)
Figure 16. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumed in Scientific Research
Figure 17. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market: Scientific Research (2021-2026) & (kg)
Figure 18. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumed in Pharmaceuticals
Figure 19. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market: Pharmaceuticals (2021-2026) & (kg)
Figure 20. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sale Market Share by Application (2025)
Figure 21. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Application in 2026
Figure 22. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Company in 2026 (kg)
Figure 23. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Company in 2026
Figure 24. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Company in 2026 ($ millions)
Figure 25. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Company in 2026
Figure 26. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Geographic Region in 2026
Figure 28. Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales 2021-2026 (kg)
Figure 29. Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue 2021-2026 ($ millions)
Figure 30. APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales 2021-2026 (kg)
Figure 31. APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue 2021-2026 ($ millions)
Figure 32. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales 2021-2026 (kg)
Figure 33. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales 2021-2026 (kg)
Figure 35. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue 2021-2026 ($ millions)
Figure 36. Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Country in 2026
Figure 37. Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Country (2021-2026)
Figure 38. Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Type (2021-2026)
Figure 39. Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Application (2021-2026)
Figure 40. United States Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Region in 2026
Figure 45. APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Region (2021-2026)
Figure 46. APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Type (2021-2026)
Figure 47. APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Application (2021-2026)
Figure 48. China Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 52. India Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Country in 2026
Figure 56. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Country (2021-2026)
Figure 57. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Type (2021-2026)
Figure 58. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Application (2021-2026)
Figure 59. Germany Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 60. France Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 61. UK Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Application (2021-2026)
Figure 67. Egypt Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Prostate-Specific Membrane Antigen(PSMA) Inhibitor in 2026
Figure 73. Manufacturing Process Analysis of Prostate-Specific Membrane Antigen(PSMA) Inhibitor
Figure 74. Industry Chain Structure of Prostate-Specific Membrane Antigen(PSMA) Inhibitor
Figure 75. Channels of Distribution
Figure 76. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Forecast by Region (2027-2032)
Figure 77. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Prostate-Specific Membrane Antigen(PSMA) Inhibitor
Figure 2. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Growth Rate 2021-2032 (kg)
Figure 7. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Country/Region (2025)
Figure 10. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Small Molecule Inhibitors
Figure 12. Product Picture of Peptide Inhibitors
Figure 13. Product Picture of Other
Figure 14. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Type in 2026
Figure 15. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Type (2021-2026)
Figure 16. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumed in Scientific Research
Figure 17. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market: Scientific Research (2021-2026) & (kg)
Figure 18. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumed in Pharmaceuticals
Figure 19. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market: Pharmaceuticals (2021-2026) & (kg)
Figure 20. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sale Market Share by Application (2025)
Figure 21. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Application in 2026
Figure 22. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales by Company in 2026 (kg)
Figure 23. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Company in 2026
Figure 24. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Company in 2026 ($ millions)
Figure 25. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Company in 2026
Figure 26. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Geographic Region in 2026
Figure 28. Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales 2021-2026 (kg)
Figure 29. Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue 2021-2026 ($ millions)
Figure 30. APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales 2021-2026 (kg)
Figure 31. APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue 2021-2026 ($ millions)
Figure 32. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales 2021-2026 (kg)
Figure 33. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales 2021-2026 (kg)
Figure 35. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue 2021-2026 ($ millions)
Figure 36. Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Country in 2026
Figure 37. Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Country (2021-2026)
Figure 38. Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Type (2021-2026)
Figure 39. Americas Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Application (2021-2026)
Figure 40. United States Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Region in 2026
Figure 45. APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Region (2021-2026)
Figure 46. APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Type (2021-2026)
Figure 47. APAC Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Application (2021-2026)
Figure 48. China Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 52. India Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Country in 2026
Figure 56. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Country (2021-2026)
Figure 57. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Type (2021-2026)
Figure 58. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Application (2021-2026)
Figure 59. Germany Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 60. France Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 61. UK Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share by Application (2021-2026)
Figure 67. Egypt Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Prostate-Specific Membrane Antigen(PSMA) Inhibitor in 2026
Figure 73. Manufacturing Process Analysis of Prostate-Specific Membrane Antigen(PSMA) Inhibitor
Figure 74. Industry Chain Structure of Prostate-Specific Membrane Antigen(PSMA) Inhibitor
Figure 75. Channels of Distribution
Figure 76. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Forecast by Region (2027-2032)
Figure 77. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share Forecast by Application (2027-2032)
